Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nature ; 548(7665): 31, 2017 08 02.
Article in English | MEDLINE | ID: mdl-28770849
2.
Prehosp Emerg Care ; 20(1): 52-8, 2016.
Article in English | MEDLINE | ID: mdl-26024309

ABSTRACT

Pain is the most common symptom in the emergency setting and remains one of the most challenging problems for emergency care providers, particularly in the pediatric population. The primary objective of this study was to determine the prevalence of acute pain in children attending emergency departments (EDs) in Ireland by ambulance. In addition, this study sought to describe the prehospital and initial ED management of pain in this population, with specific reference to etiology of pain, frequency of pain assessment, pain severity, and pharmacological analgesic interventions. A prospective cross-sectional study was undertaken over a 12-month period of all pediatric patients transported by emergency ambulance to four tertiary referral hospitals in Ireland. All children (<16 years) who had pain as a symptom (regardless of cause) at any stage during the prehospital phase of care were included in this study. Over the study period, 6,371 children attended the four EDs by emergency ambulance, of which 2,635 (41.4%, 95% confidence interval 40.2-42.3%) had pain as a documented symptom on the ambulance patient care report (PCR) form. Overall 32% (n = 856) of children who complained of pain were subject to a formal pain assessment during the prehospital phase of care. Younger age, short transfer time to the ED, and emergency calls between midnight and 6 am were independently associated with decreased likelihood of having a documented assessment of pain intensity during the prehospital phase of care. Of the 2,635 children who had documented pain on the ambulance PCR, 26% (n = 689) received some form of analgesic agent prior to ED arrival. Upon ED arrival 54% (n = 1,422) of children had a documented pain assessment and some form of analgesic agent was administered to 50% (n = 1,324). Approximately 41% of children who attend EDs in Ireland by ambulance have pain documented as their primary symptom. This study suggests that the management of acute pain in children transferred by ambulance to the ED in Ireland is currently poor, with documentary evidence of only 26% receiving prehospital analgesic agents.


Subject(s)
Analgesia/methods , Analgesics/therapeutic use , Emergency Service, Hospital , Pain Management/methods , Pain Measurement , Pain/epidemiology , Adolescent , Ambulances , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Ireland/epidemiology , Male , Prevalence , Prospective Studies , Severity of Illness Index
3.
FEBS Lett ; 589(13): 1491-7, 2015 Jun 04.
Article in English | MEDLINE | ID: mdl-25959868

ABSTRACT

Mechanically-induced skeletal muscle growth is regulated by mammalian/mechanistic target of rapamycin complex 1 (mTORC1). Yes-Associated Protein (YAP) is a mechanically-sensitive, and growth-related, transcriptional co-activator that can regulate mTORC1. Here we show that, in skeletal muscle, mechanical overload promotes an increase in YAP expression; however, the time course of YAP expression is markedly different from that of mTORC1 activation. We also show that the overexpression of YAP induces hypertrophy via an mTORC1-independent mechanism. Finally, we provide preliminary evidence of possible mediators of YAP-induced hypertrophy (e.g. increased MyoD and c-Myc expression, and decreased Smad2/3 activity and muscle ring finger 1 (MuRF1) expression).


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Muscle, Skeletal/metabolism , Phosphoproteins/metabolism , Up-Regulation , Adaptor Proteins, Signal Transducing/genetics , Animals , Blotting, Western , Cell Cycle Proteins , Female , Gene Expression Regulation , Hypertrophy , Male , Mechanistic Target of Rapamycin Complex 1 , Mice , Microscopy, Fluorescence , Multiprotein Complexes/metabolism , Muscle Proteins/genetics , Muscle, Skeletal/pathology , MyoD Protein/genetics , Phosphoproteins/genetics , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-myc/genetics , Signal Transduction , Smad2 Protein/metabolism , Smad3 Protein/metabolism , Stress, Mechanical , TOR Serine-Threonine Kinases/metabolism , Tripartite Motif Proteins , Ubiquitin-Protein Ligases/genetics , YAP-Signaling Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...